The oversight board tasked one of its members—Dr Andrew Murray, who is the co-chair of the managed clinical network for children’s cancer services in Scotland—to meet with a multidisciplinary team of senior clinicians, on 6 December, for a clinician-led review of the use of those medicines. The front-line team has confirmed to Dr Murray that the use of anti...